StockTipsArenaBeta

SELL Biocon Ltd — Bernstein

SELLBiocon Ltd
Biocon share price target & all analyst calls

byBernsteinHorizon: NA (inferred 1 year)15 Jul 2026via CNBC Awaaz.

Entry₹438Inferred
Target₹326
Total upside +25.57% (call closed)
Stop lossNot given
Exit₹32623 Oct 2026, 9:48 am
Target hit+25.57%0.00%upside left
Follow Bernstein for new callsGet alertsWatch BIOCON for new buy/sell callsGet alertsSee 10 active Long-term calls on BIOCON

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 23 Oct 2026
5 supporting12 neutral36 opposing
Supports the SELL call (5)

1 advisor has an active short-term SELL call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·9 Oct · 2w ago

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·14 Nov · 11mo ago

Neutral / worth noting (12)

Nothing found in this tip’s window yet.

Weighs against the SELL call (36)

Biocon settles licence agreement with Genetech for cancer treatment drug — Check earliest secured launch dates

NewsCnbc-Tv18·14 Oct · 1w ago

(opens in new tab)

Biocon Malaysia arm gets UK regulator approval for Semglee fill finish unit

NewsCnbc-Tv18·25 Sept · 4w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·19 Sept · 1mo ago

6 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·7 Aug · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Biocon

All analyst calls on Biocon

More from Bernstein

Every call and its outcome